Mindset Pharma Inc
Change company Symbol lookup
Select an option...
MSSTF Mindset Pharma Inc
SASOF Sasol Ltd
SMBC Southern Missouri Bancorp Inc
ALG Alamo Group Inc
AFFCF American Future Fuel Corp
TDS-U Telephone and Data Systems Inc
FRSH Freshworks Inc
TA Travelcenters of America Inc
WWW Wolverine World Wide Inc
$PABEZ5T Bloomberg PAB Eurozone 50 Decrement
Go

Health Care : Pharmaceuticals |
Based in Canada
Company profile

Mindset Pharma Inc. is a Canada-based drug discovery and development company. The Company is engaged in the psychedelic-based drug discovery business focused on creating patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. Its drug development platform seeks to advance medicines based on psychedelic substances through rigorous scientific and clinical trials, performed by third-party contract research organizations. The Company has developed 4 families of next-generation psychedelics with differentiated characteristics. The Company's portfolio consists of macrodosing and microdosing. Its macrodosing includes Family 1/MSP-1014, Family 2, and Family 4. The MSP-1014 is a new chemical entity that incorporates a conjugated amplifier into a psilocybin-like structure to create an effective drug. The Company's Family 3 is a long-acting next-generation psychedelic drug positioned for micro-dosing.

Closing Price
$0.30
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
2,116

10-day average volume:
9,572
2,116

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, November 30, 2022
November 16, 2022
November 14, 2022
October 27, 2022
October 05, 2022
September 27, 2022
September 14, 2022
Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

EQNX::TICKER_START (CNSX:MSET.CN),(OTC US:MSSTF),(Other OTC:MSSTF),(Boerse Frankfurt - Freiverkehr:9DF), EQNX::TICKER_END Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery company developing...(Globe Newswire)

September 07, 2022
Mindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries

EQNX::TICKER_START (CNSX:MSET.CN),(OTC US:MSSTF),(Other OTC:MSSTF),(Boerse Frankfurt - Freiverkehr:9DF), EQNX::TICKER_END Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.